Blockchain Registration Transaction Record
Onco-Innovations Combines AI and Nanoparticles to Target Cancer
Onco-Innovations is advancing ONC010, a PNKP inhibitor with nanoparticle delivery, and SynoGraph AI to improve cancer treatment. Learn about their integrated approach.
This news matters because it highlights a novel approach in oncology that could lead to more effective cancer treatments with fewer side effects. The integration of PNKP inhibitors with nanoparticle delivery systems addresses critical issues like drug solubility and tumor accumulation. Additionally, the use of AI in patient selection and trial design promises to accelerate the development of personalized cancer therapies, potentially improving outcomes for patients worldwide.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0x7f7e7692391bfccf663850f68c5946130398df415b23e4bfb1c19385713df2d9 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | seekaDoL-f15f7c416f722bb64871b17755d62e31 |